These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 23009795)

  • 1. Comparing the joint effect of arsenic exposure, cigarette smoking and risk genotypes of vascular endothelial growth factor on upper urinary tract urothelial carcinoma and bladder cancer.
    Wang YH; Yeh SD; Wu MM; Liu CT; Shen CH; Shen KH; Pu YS; Hsu LI; Chiou HY; Chen CJ
    J Hazard Mater; 2013 Nov; 262():1139-46. PubMed ID: 23009795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A significantly joint effect between arsenic and occupational exposures and risk genotypes/diplotypes of CYP2E1, GSTO1 and GSTO2 on risk of urothelial carcinoma.
    Wang YH; Yeh SD; Shen KH; Shen CH; Juang GD; Hsu LI; Chiou HY; Chen CJ
    Toxicol Appl Pharmacol; 2009 Nov; 241(1):111-8. PubMed ID: 19686770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of cigarette smoke and arsenic exposure on urothelial carcinoma risk is modified by glutathione S-transferase M1 gene null genotype.
    Chung CJ; Huang CY; Pu YS; Shiue HS; Su CT; Hsueh YM
    Toxicol Appl Pharmacol; 2013 Jan; 266(2):254-9. PubMed ID: 23159782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphism of inflammatory genes and arsenic methylation capacity are associated with urothelial carcinoma.
    Wu CC; Huang YK; Chung CJ; Huang CY; Pu YS; Shiue HS; Lai LA; Lin YC; Su CT; Hsueh YM
    Toxicol Appl Pharmacol; 2013 Oct; 272(1):30-6. PubMed ID: 23727622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of arsenic methylation capacity and polymorphisms of arsenic methylation genes between bladder cancer and upper tract urothelial carcinoma.
    Huang CY; Lin YC; Shiue HS; Chen WJ; Su CT; Pu YS; Ao PL; Hsueh YM
    Toxicol Lett; 2018 Oct; 295():64-73. PubMed ID: 29859237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in cell cycle regulatory genes, urinary arsenic profile and urothelial carcinoma.
    Chung CJ; Huang CJ; Pu YS; Su CT; Huang YK; Chen YT; Hsueh YM
    Toxicol Appl Pharmacol; 2008 Oct; 232(2):203-9. PubMed ID: 18640142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arsenic methylation capability, myeloperoxidase and sulfotransferase genetic polymorphisms, and the stage and grade of urothelial carcinoma.
    Huang SK; Chiu AW; Pu YS; Huang YK; Chung CJ; Tsai HJ; Yang MH; Chen CJ; Hsueh YM
    Urol Int; 2009; 82(2):227-34. PubMed ID: 19322015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
    Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
    Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of hOGG1 and XPD polymorphisms with urothelial carcinoma in Taiwan.
    Wang YH; Yeh SD; Shen KH; Shen CH; Tung MC; Liu CT; Chiou HY
    Anticancer Res; 2011 Nov; 31(11):3939-44. PubMed ID: 22110223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary arsenic profile affects the risk of urothelial carcinoma even at low arsenic exposure.
    Pu YS; Yang SM; Huang YK; Chung CJ; Huang SK; Chiu AW; Yang MH; Chen CJ; Hsueh YM
    Toxicol Appl Pharmacol; 2007 Jan; 218(2):99-106. PubMed ID: 17196235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. XPD codon 751 polymorphism, metabolism genes, smoking, and bladder cancer risk.
    Stern MC; Johnson LR; Bell DA; Taylor JA
    Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1004-11. PubMed ID: 12376500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy.
    Shen M; Hung RJ; Brennan P; Malaveille C; Donato F; Placidi D; Carta A; Hautefeuille A; Boffetta P; Porru S
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1234-40. PubMed ID: 14652287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between cigarette smoking and XPC-PAT genetic polymorphism enhance bladder cancer risk.
    Liu Y; Wang H; Lin T; Wei Q; Zhi Y; Yuan F; Song B; Yang J; Chen Z
    Oncol Rep; 2012 Jul; 28(1):337-45. PubMed ID: 22505326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
    Okkels H; Sigsgaard T; Wolf H; Autrup H
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human NAD(P)H:quinone oxidoreductase 1 (NQO1) and sulfotransferase 1A1 (SULT1A1) polymorphisms and urothelial cancer risk in Taiwan.
    Wang YH; Lee YH; Tseng PT; Shen CH; Chiou HY
    J Cancer Res Clin Oncol; 2008 Feb; 134(2):203-9. PubMed ID: 17619904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer.
    Hsieh FI; Pu YS; Chern HD; Hsu LI; Chiou HY; Chen CJ
    Br J Cancer; 1999 Oct; 81(3):537-41. PubMed ID: 10507782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic concentrations in prediagnostic toenails and the risk of bladder cancer in a cohort study of male smokers.
    Michaud DS; Wright ME; Cantor KP; Taylor PR; Virtamo J; Albanes D
    Am J Epidemiol; 2004 Nov; 160(9):853-9. PubMed ID: 15496537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms of glutathione S-transferase μ and θ, MDR1 and VEGF genes as risk factors of bladder cancer: a case-control study.
    Henríquez-Hernández LA; Navarro P; Luzardo OP; Alvarez-León EE; Boada LD; Zumbado M; Pestano J; Suárez JR; Chesa N; Almeida M; Valerón PF
    Urol Oncol; 2012 Sep; 30(5):660-5. PubMed ID: 21292509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphism of glutathione S-transferases M1 and T1 as a risk factor in lung and bladder cancers.
    Salagovic J; Kalina I; Stubna J; Habalová V; Hrivnák M; Valanský L; Kohút A; Biros E
    Neoplasma; 1998; 45(5):312-7. PubMed ID: 9921921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined effects of GSTO1 and SULT1A1 polymorphisms and cigarette smoking on urothelial carcinoma risk in a Taiwanese population.
    Tung MC; Wang YH; Yeh SD; Wu CC; Chen KC; Huang ZM; Huang MT; Chiou HY
    J Formos Med Assoc; 2014 Sep; 113(9):640-7. PubMed ID: 25103078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.